Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
0.9057
-0.0251 (-2.70%)
At close: Sep 11, 2026, 4:00 PM EDT
0.8915
-0.0142 (-1.57%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Health In Tech Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Health In Tech stock has a consensus rating of "Buy" and an average price target of $3.70. The average 1-year stock price forecast is 308.52% higher than the current stock price, while the lowest is $3.00 (+231.24%) and the highest is $4.10 (+352.69%).
Price Target: $3.70 (+308.52%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 14, 2026.
Analyst Ratings
The average analyst rating for Health In Tech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $4 | Buy | Reiterates | $4 | +341.65% | Aug 14, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +231.24% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
41.19M
from 33.33M
Increased by 23.60%
Revenue Next Year
71.23M
from 41.19M
Increased by 72.90%
EPS This Year
-0.11
from 0.02
EPS Next Year
0.04
from -0.11
EPS and Forward PE are based on non-GAAP adjusted numbers.